News & Analysis

A pivotal life sciences investment for London’s Canary Wharf

Canary Wharf Group and AXA IM Alts' Kadans Science Partner will be investing £500m in Europe's largest commercial lab building.

By

Jessica Nangle

13 May 2022•2 mins read

Managers Europe

Related articles

alt

‘A much more dynamic affair’: Inside PERE’s next chapter

15 July 2026 · 10 mins read

alt

La Caisse’s Horstmann: ‘We’re not shying away from the US’

14 July 2026 · 4 mins read

alt

2019-23 vintage funds have distributed 50% or less of capital

14 July 2026 · 2 mins read

alt

PIMCO’s Trausch: Real estate’s ‘fight for relevance’ in age of AI

14 July 2026 · 4 mins read

alt

LACERA’s real estate head departs after two years

13 July 2026 · 3 mins read

alt

DOWNLOAD: Real estate fundraising falls to nine-year low in H1 2026

10 July 2026 · 2 mins read

alt

Henderson Park taps Cerberus veteran to aid US expansion

9 July 2026 · 2 mins read

motif